CN112672734B - 包含蛋白质和聚烷氧基脂肪酰基表面活性剂的组合物 - Google Patents

包含蛋白质和聚烷氧基脂肪酰基表面活性剂的组合物 Download PDF

Info

Publication number
CN112672734B
CN112672734B CN201980059505.6A CN201980059505A CN112672734B CN 112672734 B CN112672734 B CN 112672734B CN 201980059505 A CN201980059505 A CN 201980059505A CN 112672734 B CN112672734 B CN 112672734B
Authority
CN
China
Prior art keywords
composition
protein
units
fatty acyl
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980059505.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN112672734A (zh
Inventor
J·S·卡茨
S·L·乔丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Global Technologies LLC
Original Assignee
Dow Global Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies LLC filed Critical Dow Global Technologies LLC
Publication of CN112672734A publication Critical patent/CN112672734A/zh
Application granted granted Critical
Publication of CN112672734B publication Critical patent/CN112672734B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201980059505.6A 2018-09-10 2019-09-06 包含蛋白质和聚烷氧基脂肪酰基表面活性剂的组合物 Active CN112672734B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862729140P 2018-09-10 2018-09-10
US62/729140 2018-09-10
US201962850688P 2019-05-21 2019-05-21
US62/850688 2019-05-21
PCT/US2019/049904 WO2020055679A2 (en) 2018-09-10 2019-09-06 A composition comprising a protein and a polyalkoxy fatty acyl surfactant

Publications (2)

Publication Number Publication Date
CN112672734A CN112672734A (zh) 2021-04-16
CN112672734B true CN112672734B (zh) 2023-04-11

Family

ID=68000095

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980059505.6A Active CN112672734B (zh) 2018-09-10 2019-09-06 包含蛋白质和聚烷氧基脂肪酰基表面活性剂的组合物

Country Status (6)

Country Link
US (1) US20260115292A1 (cg-RX-API-DMAC10.html)
EP (1) EP3849519B1 (cg-RX-API-DMAC10.html)
JP (1) JP2022500376A (cg-RX-API-DMAC10.html)
KR (1) KR20210056349A (cg-RX-API-DMAC10.html)
CN (1) CN112672734B (cg-RX-API-DMAC10.html)
WO (1) WO2020055679A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4073084A1 (en) * 2019-12-12 2022-10-19 Nutrition & Biosciences USA 1, LLC Protein bioprocess
CN116348475A (zh) * 2020-07-15 2023-06-27 营养与生物科学美国1有限责任公司 表面上结垢减少的生物工艺

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104023748A (zh) * 2011-10-28 2014-09-03 诚信生物公司 含有氨基酸的蛋白质制剂
WO2017044367A1 (en) * 2015-09-11 2017-03-16 Dow Global Technologies Llc A composition comprising a protein and a polyalkoxy fatty compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005011608A1 (de) * 2005-03-14 2006-09-21 Basf Ag Veresterte Alkylalkoxylate als schaumarme Tenside
JP2015506369A (ja) * 2012-01-30 2015-03-02 アレコー リミテッド 安定化された水性抗体組成物
DK3347403T3 (da) 2015-09-11 2020-06-29 Dow Global Technologies Llc Polyalkoxyfedtforbindelse

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104023748A (zh) * 2011-10-28 2014-09-03 诚信生物公司 含有氨基酸的蛋白质制剂
WO2017044367A1 (en) * 2015-09-11 2017-03-16 Dow Global Technologies Llc A composition comprising a protein and a polyalkoxy fatty compound

Also Published As

Publication number Publication date
JP2022500376A (ja) 2022-01-04
EP3849519A2 (en) 2021-07-21
EP3849519B1 (en) 2022-09-21
US20260115292A1 (en) 2026-04-30
KR20210056349A (ko) 2021-05-18
CN112672734A (zh) 2021-04-16
WO2020055679A2 (en) 2020-03-19
WO2020055679A3 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
US11660343B2 (en) Viscosity-reducing excipient compounds for protein formulations
CN109071657B (zh) 包含双特异性抗体构建体的药物组合物
AU2013255413B2 (en) Pharmaceutical formulations of TNF-alpha antibodies
AU735411B2 (en) Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
JP5405122B2 (ja) 低粘度のタンパク質製剤およびその用途
US11696951B2 (en) Viscosity-reducing compounds for protein formulations
US20230065872A1 (en) Excipient compounds for protein processing
CN101420972A (zh) 降低蛋白质聚集的方法
JP2004538287A (ja) IgG抗体の安定な凍結乾燥医薬製剤
US10758621B2 (en) Liquid formulation comprising GM-CSF neutralizing compound
US20260115292A1 (en) Composition comprising a protein and a polyalkoxy fatty acyl surfactant
KR102572453B1 (ko) 단백질 가공 처리를 위한 부형제 화합물
EP3347403B1 (en) Polyalkoxy fatty compound
CA3120023A1 (en) Excipient compounds for protein processing
US20210379185A1 (en) Excipient compounds for protein processing
JP2026062713A (ja) タンパク質のバイオプロセス
CA3159377A1 (en) Excipient compounds for biopolymer formulations
US20210322554A1 (en) A composition comprising a protein and a polyalkoxy fatty acyl surfactant

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant